Evidence map›Paper›PMID 35125884›Full record

ArticleInternational journal of general medicine2022

Bioinformatics Analysis of Prognostic Value of

Jipeng Zhang, Xinlei Chen, Jirong Wang, Pengfei Zhang, Xue Han, Youzhi Zhang, Yonghua Wang, Xiaokun Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of general medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jipeng ZhangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
Xinlei ChenDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
Jirong WangDepartment of Urology, The Second Affiliated Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China.ORCID 0000-0003-4223-3497
Pengfei ZhangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
Xue HanDepartment of Oncology, The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong, People's Republic of China.
Youzhi ZhangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
Yonghua WangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.ORCID 0000-0002-8861-1003
Xiaokun YangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
Qingdao University · CNAffiliated Hospital of Taishan Medical University · CNLanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeClear cell renal cell carcinoma (ccRCC) is one of the most common diseases in the world, with high morbidity and mortality. Recent studies have revealed the important role of MATERIALS AND

methodsBased on data from public databases, we determined the expression level and clinical value of

results

conclusionOur study revealed that

Indexed as

bioinformaticsclear cell renal cell carcinomagene expressionpan-cancerprognosisSPC24

Identifiers

PMID35125884
PMCPMC8807948
OpenAlexW4206931345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.